Delgado, Y.; Torres-Sanchez, A.; Perez, D.; Torres, G.; Estrada, S.; Ortiz Alvelo, N.; Vega, J.; Santos, L.; Torres, A.; Madera, B.A.;
et al. Deferasirox’s Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma. Biomedicines 2024, 12, 2272.
https://doi.org/10.3390/biomedicines12102272
AMA Style
Delgado Y, Torres-Sanchez A, Perez D, Torres G, Estrada S, Ortiz Alvelo N, Vega J, Santos L, Torres A, Madera BA,
et al. Deferasirox’s Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma. Biomedicines. 2024; 12(10):2272.
https://doi.org/10.3390/biomedicines12102272
Chicago/Turabian Style
Delgado, Yamixa, Anamaris Torres-Sanchez, Daraishka Perez, Grace Torres, Sthephanie Estrada, Natalia Ortiz Alvelo, Jaisy Vega, Laurie Santos, Aracelis Torres, Bismark A. Madera,
and et al. 2024. "Deferasirox’s Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma" Biomedicines 12, no. 10: 2272.
https://doi.org/10.3390/biomedicines12102272
APA Style
Delgado, Y., Torres-Sanchez, A., Perez, D., Torres, G., Estrada, S., Ortiz Alvelo, N., Vega, J., Santos, L., Torres, A., Madera, B. A., & Ferrer-Acosta, Y.
(2024). Deferasirox’s Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma. Biomedicines, 12(10), 2272.
https://doi.org/10.3390/biomedicines12102272